Impaired expression of
alpha-defensin antimicrobial peptides and overproduction of the proinflammatory
cytokine IL-1beta have been associated with
inflammatory bowel disease. In this study, we examine the interactions between
alpha-defensins and IL-1beta and the role of
defensin deficiency in the pathogenesis of
inflammatory bowel disease. It was found that matrix metalloproteinase-7-deficient (
MMP-7(-/-)) mice, which produce procryptdins but not mature cryptdins (
alpha-defensins) in the intestine, were more susceptible to
dextran sulfate sodium-induced
colitis. Furthermore, both baseline and
dextran sulfate sodium-induced IL-1beta production in the intestine were significantly up-regulated in
MMP-7(-/-) mice compared with that in control C57BL/6 mice. To elucidate the molecular mechanism for the increased IL-1beta production in
defensin deficiency in vivo, we evaluated the effect of
defensins on IL-1beta posttranslational processing and release. It was found that
alpha-defensins, including mouse Paneth cell
defensins cryptdin-3 and cryptdin-4, human neutrophil
defensin HNP-1, and human Paneth cell
defensin HD-5, blocked the release of IL-1beta from LPS-activated monocytes, whereas
TNF-alpha expression and release were not affected. Unlike
alpha-defensins, human
beta-defensins and mouse procryptdins do not have any effect on IL-1beta processing and release. Thus,
alpha-defensins may play an important role in intestinal homeostasis by controlling the production of IL-1beta.